NDC 70297-003 - Capecitabine Tablets, 150 mg

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 70297-003
Package NDCs from labels: 70297-003-02
Manufacturer: Prodigy Innovation, LLC.
Effective date: 2019-04-21
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Capecitabine Tablets, USP 150 mg and 500 mg	Prodigy Innovation, LLC.	2019-04-21	HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
70297-003-02	2021-01-29	C162847	48780-1	ba0f9c33-58e3-a910-e053-dadaa90a0b85	Capecitabine Tablets, USP 150 mg and 500 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
70297-003-02	Capecitabine Tablets, 150 mg	25000 in 1 BAG	TABLET	25000		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70297-003	CAPECITABINE TABLETS, 150 MG TABLET CAPECITABINE TABLETS, 500 MG TABLET [PRODIGY INNOVATION, LLC.]	1	1 package rows	20190501_87173e7c-6e29-2e85-e053-2a91aa0ae4ae.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 21 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
87173e7c-6e2a-2e85-e053-2a91aa0ae4ae			87173e7c-6e29-2e85-e053-2a91aa0ae4ae	2019-04-21		Exact identifier spl id: 87173e7c-6e2a-2e85-e053-2a91aa0ae4ae spl set id: 87173e7c-6e29-2e85-e053-2a91aa0ae4ae

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.